PM
SCMP

Penbrook Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Penbrook Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-42,825
Closed -$295K – 127
2014
Q2 		$295K Sell
42,825
-26,900
-39% -$190K 0.26% 89
2014
Q1 		$499K Hold
69,725
– – 0.47% 72
2013
Q4 		$655K Buy
+69,725
New +$497K 0.64% 65

Other funds holding SCMP

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Penbrook Management's SCMP Position: Q3 2014 in Review

Penbrook Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2014, closing a stake of 42,825 shares — an estimated $295K sold.

Penbrook Management first reported a position in SCMP in Q4 2013 and held it in 3 quarters. The position peaked at $655K in Q4 2013. 69 funds tracked by Wall St. Rank hold SCMP as of Q3 2014.

  • Penbrook Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • Penbrook Management sold 42,825 Sucampo Pharmaceuticals, Inc. shares in Q3 2014, an estimated $295K.
  • Penbrook Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2013 and held it in 3 quarters.
  • Penbrook Management's Sucampo Pharmaceuticals, Inc. position peaked at $655K in Q4 2013.
  • 69 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2014.

Based on Penbrook Management's 13F filing for Q3 2014, filed 16 Oct 2014.